Category: PET Imaging

SNMMI Highlighting PET/MRI and Therapeutics in Two Unique Events

Therapeutics and PET/MRI are both areas of intense focus and innovation in nuclear medicine. The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is actively working to help members stay ahead of trends by holding two innovative conferences later this month that showcase these two topics. On October 25 –

Read More »

The Clinical Impact of Utilizing NETSPOT

NETSPOT (68Ga-Dotatate) is a radioactive diagnostic agent used for PET imaging that is gaining ground among practices. FDA-approved in 2016, NETSPOT is used in imaging to locate somatostatin receptor positive neuroendocrine tumors in adult and pediatric patients. The commercial product is a single dose kit for the preparation of a

Read More »

PET/CT Imaging New Tracer Guide

The landscape of PET/CT imaging is rapidly changing. Traditionally, physicians have used a sugar based radiopharmaceutical, 18Fluorodeoxyglucose or 18FDG, to perform the majority of PET/CT imaging. Over the past 20 years, this imaging agent was the only option available to many facilities across the United States. Recent breakthroughs in research, reimbursement,

Read More »
Making Healthcare Convenient. As Needed. When Needed. Where Needed.

Sign Up!

Subscribe to the Digirad Newsletter for the latest updates.

©2021 Digirad Corporation. All rights reserved.